PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) Stock Price, Quote, News & History

Key Data

See all statistics →

Open

$0.04

Volume / Avg.

585.13K / 120.76K

Day Range

$0.04 - $0.05

52 Wk Range

0.04 - 0.08

Exchange

OTC

Days to Cover

4.57

Press Releases

See all news →

VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company ShowcaseJul 22, 2026
Independent University of Lille Study Shows Rose Bengal Sodium Produces Opposing Mechanistic Effects at the Same DoseJul 7, 2026
Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular InfectionsJun 30, 2026
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)Jun 25, 2026
Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of StockholdersJun 8, 2026

Key Events for PVCT

See All Market Events for PVCT →

EventDateTimeAmount

Q2 2026 EPS
Aug 13, 2026 · 2:00 PM
Aug 13, 2026
2:00 PM
$0.00
Q3 2026 Earnings
Nov 24, 2026 · 2:00 PM
Nov 24, 2026
2:00 PM
—

Edge Rankings

About PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc.

Sector

Health Care

Industry

Pharmaceuticals

Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of bioactive synthetic small molecule halogenated xanthenes (HXs). Its flagship HX molecule is named...

FAQ

How do I buy PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) stock?

You can purchase shares of PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT) through any online brokerage.

View our list of the best stock brokerages

Who are PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) competitors?

There are no as such competitors for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc..

What is the forecast, or price target, for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) stock?

There is no analysis for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. to provide a consensus price target.

What is the current price for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT)?

The stock price for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is $0.041 last updated November 12, 2026 at 2:22 PM EST.

Does PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) pay a dividend?

There are no upcoming dividends for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc..

When is PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT) reporting earnings?

PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. does not have any upcoming earnings scheduled.

Is PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) going to split?

There is no upcoming split for PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc..

What sector and industry does PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. (PVCT) operate in?

PROVECTUS BIOPHARMS by Provectus Biopharmaceuticals, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

FAQ